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Cambridge Vascular Unit, Box 201, Level 6, Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 2QQ, UKElective abdominal aortic aneurysm (AAA) repair is under-
taken to prevent aneurysm rupture. In an individual patient
we cannot predict when an aneurysm will rupture, but most
vascular surgeons offer intervention when the AAA reaches
5.5 cm in maximum diameter, based on the results of the
UK small aneurysm trial.1 Inevitably however many patients
will have aneurysms repaired that would not go on to
rupture, if left untreated, before they succumb to other
natural causes.
Perhaps the most important ﬁnding of this manuscript,2
reporting the mid-term follow-up3 of young patients un-
dergoing AAA repair, is that life expectancy even in this
group is poor. The authors report a mortality of 40% at a
median follow-up of 6 years and 5 months. To put this into
context, mortality in the UK small aneurysm trial was 44% at
8 years and 64% 12 years after randomization.1 The median
age at randomization in this study was 69 years compared
with the 61 years reported by Atlaf et al.2 One would
anticipate with further follow-up a mortality of approxi-
mately 50% at 8 years in line with the EVAR 1 trial (46%)4
and other reports.5 In other words, it would appear that
young aortic aneurysm patients are no ﬁtter than their
older counterparts, with the presence of an aortic aneurysm
alone identifying patients at risk of premature death from
associated co-morbidity.
Furthermore, life expectancy for a man aged 61 years has
risen in the UK from 17 to 21 years over the period of this
study (1994e2010).6 Patients with an aortic aneurysm at
this age appear to have on average half the life expectancy
of the general population, dispelling the popularly held
misconception that once an AAA has been repaired life
expectancy reverts to that of the population as a whole. Put
simply, aortic aneurysm repair does not protect a patient
from death as a result of associated comorbidity such as
ischaemic heart disease or malignancy.
There are a number of methodological problems with this
manuscript. The retrospective data collection, incomplete
dataset with patients lost to follow-up and change in
endovascular aneurysm repair (EVAR) practice over the 18-
year period mean that we should interpret the ﬁndings with
some caution. It is not surprising that results for commer-
cially available stent-grafts appear better than for the
custom-made devices. In particular, the authors report
lower re-intervention rates for newer generation grafts inDOI of original article: http://dx.doi.org/10.1016/j.ejvs.2013.04.027
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http://dx.doi.org/10.1016/j.ejvs.2013.05.020keeping with other data. However, these patients have had
a shorter duration of follow-up.
Younger AAA patients may well have more favourable
anatomy for EVAR with potentially smaller aneurysm size.
Furthermore, softer, less calciﬁed aortas potentially have a
better ability to remodel.7 Younger male patients may also
be keen to avoid complications from open repair, in
particular impotence. Therefore in anatomically suitable
aneurysms in young patients, I will offer EVAR with a low
permeability graft material, PTFE, which often results in
rapid reduction in AAA size or even aneurysm resolution in
a relatively short time frame.8 My decision-making places
more weight on anatomical suitability for EVAR with patient
ﬁtness a lesser consideration.
It appears that aortic aneurysm patients are not as ﬁt as the
general population and have shorter life expectancy irre-
spective of the age at which they present. This in conjunction
with better outcomes for EVAR with contemporary commer-
cially available devices logically would suggest that the deci-
sion to offer open or endovascular repair should be based
primarily on aneurysm morphology even in younger patients.
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